Zukin, R. Suzanne

NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders

Lau, C. G., & Zukin, R. S. (2007) · Nature Reviews Neuroscience

Neuroscience and Neuropharmacology ResearchGenetics and Neurodevelopmental Disorders

Cited by 1,159

Dysregulation of mTOR signaling in fragile X syndrome

Sharma, A., Hoeffer, C. A., Takayasu, Y., Miyawaki, T., McBride, S. M., Klann, E., & Zukin, R. S. (2010) · The Journal of Neuroscience

Genetics and Neurodevelopmental DisordersPI3K/AKT/mTOR signaling in cancer

Cited by 557

Ca2+-permeable AMPA receptors in synaptic plasticity and neuronal death

Liu, S. J., & Zukin, R. S. (2007) · Trends in Neurosciences

Neuroscience and Neuropharmacology ResearchAmino Acid Enzymes and Metabolism

Cited by 530

A synaptic perspective of fragile X syndrome and autism spectrum Disorders.

Bagni, C., & Zukin, R. S. (2019) · Neuron

Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research

Cited by 326

Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome

Hoeffer, C. A., Sanchez, E., Hagerman, R. J., Mu, Y., Nguyen, D. V., Wong, H., Whelan, A. M., Zukin, R. S., Klann, E., & Tassone, F. (2012) · Genes, Brain and Behavior

Genetics and Neurodevelopmental DisordersRNA and protein synthesis mechanisms

Cited by 198

Dysregulation of Mammalian Target of Rapamycin Signaling in Mouse Models of Autism

Huber, K. M., Klann, E., Costa-Mattioli, M., & Zukin, R. S. (2015) · The Journal of Neuroscience

Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research

Cited by 167

Regulation of NMDA receptor Ca2+ signalling and synaptic plasticity

Lau, C. G., Takeuchi, K., Rodenas-Ruano, A., Takayasu, Y., Murphy, J., Bennett, M. V. L., & Zukin, R. S. (2009) · Biochemical Society Transactions

Neuroscience and Neuropharmacology ResearchTreatment of Major Depression

Cited by 138

Aberrant Rac1-cofilin signaling mediates defects in dendritic spines, synaptic function, and sensory perception in fragile X syndrome

Pyronneau, A., He, Q., Hwang, J.-Y., Porch, M., Contractor, A., & Zukin, R. S. (2017) · Science Signaling

Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research

Cited by 122

SNAP-25 is a target of protein kinase C phosphorylation critical to NMDA receptor trafficking

Lau, C. G., Takayasu, Y., Rodenas-Ruano, A., Paternain, A. V., Lerma, J., Bennett, M. V. L., & Zukin, R. S. (2010) · The Journal of Neuroscience

Neuroscience and Neuropharmacology ResearchCellular transport and secretion

Cited by 120

Elevated ERK/p90 ribosomal S6 kinase activity underlies audiogenic seizure susceptibility in fragile X mice

Sawicka, K., Pyronneau, A., Chao, M., Bennett, M. V. L., & Zukin, R. S. (2016) · Proceedings of the National Academy of Sciences

Genetics and Neurodevelopmental DisordersRNA and protein synthesis mechanisms

Cited by 84

Multiple drug treatments that increase cAMP signaling restore long-term memory and aberrant signaling in fragile X syndrome models

Choi, C. H., Schoenfeld, B. P., Bell, A. J., Hinchey, J., Rosenfelt, C., Gertner, M. J., Campbell, S. R., Emerson, D., Hinchey, P., Kollaros, M., et al. (2016) · Frontiers in Behavioral Neuroscience

Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research

Cited by 46